Catherine Nutt
Affiliations: | Pathology | Massachusetts General Hospital, Boston, MA |
Area:
Neuro-OncologyWebsite:
http://www.dfhcc.harvard.edu/index.php?id=2162&print=1&no_cache=1&tx_dfhccmemberprofile_pi1[memberID]=949Google:
"Catherine Nutt"Mean distance: 16.49 (cluster 24) | S | N | B | C | P |
Cross-listing: Neuropathology Tree
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Camelo-Piragua S, Jansen M, Ganguly A, et al. (2011) A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53. Journal of Neuropathology and Experimental Neurology. 70: 110-5 |
| Colman H, Zhang L, Sulman EP, et al. (2010) A multigene predictor of outcome in glioblastoma. Neuro-Oncology. 12: 49-57 |
| Camelo-Piragua S, Jansen M, Ganguly A, et al. (2010) Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis. Acta Neuropathologica. 119: 509-11 |
| Quant EC, Silver M, Yip S, et al. (2009) Case-control study of long-term survivors of glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e13021 |
| Yip S, Miao J, Cahill DP, et al. (2009) MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4622-9 |
| de la Iglesia N, Konopka G, Lim KL, et al. (2008) Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 5870-8 |
| Mueller W, Nutt CL, Ehrich M, et al. (2007) Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene. 26: 583-93 |
| Mizoguchi M, Betensky RA, Batchelor TT, et al. (2006) Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. Journal of Neuropathology and Experimental Neurology. 65: 1181-8 |
| Rousseau A, Nutt CL, Betensky RA, et al. (2006) Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2. Journal of Neuropathology and Experimental Neurology. 65: 1149-56 |
| Nutt CL. (2005) Molecular genetics of oligodendrogliomas: a model for improved clinical management in the field of neurooncology. Neurosurgical Focus. 19: E2 |